Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 8/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.32 |
| ▸ | WEE1 | P30291 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.31 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.31 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31408898 | 0.79 | AURKA (0.42) | AURKAKDRCDK2KDM4CHDAC1 | |
| SCHEMBL15416821 | 0.74 | KDR (0.47) | AURKAKDRCDK2KDM4CHDAC1 | |
| SCHEMBL19965173 | 0.73 | HDAC6 (0.44) | AURKAKDRCDK2KDM4CHDAC1 | |
| SCHEMBL630634 | 0.73 | HDAC6 (0.41) | AURKAKDRCDK2KDM4CHDAC1 | |
| SCHEMBL15416944 | 0.71 | CDK2 (0.47) | AURKAKDRCDK2KDM4CHDAC1 | |
| SCHEMBL15416935 | 0.71 | CDK2 (0.44) | AURKAKDRCDK2 | |
| SCHEMBL29881143 | 0.71 | ALDH1A1 (0.39) | AURKAKDRCDK2KDM4CHDAC1 | |
| SCHEMBL26259949 | 0.70 | CDK2 (0.42) | AURKAKDRCDK2KDM4CHDAC1 | |
| SCHEMBL26259996 | 0.70 | AURKA (0.48) | AURKAKDRCDK2KDM4CHDAC1 | |
| Hydrochloric Acid SCHEMBL7988951 | 0.70 | HDAC6 (0.40) | AURKAKDRCDK2KDM4CHDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190194386-A1 | Conducting Polymers and Uses Thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194386-A1 | Conducting Polymers and Uses Thereof | POLI, PARG, PARN | AURKA 3681/4885KDR 2821/4885CDK2 4652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.